Skip to content
Why you as a health care supplier should join us...
For-profit health care services is a fast-growing customer segment for medtech, pharma and services. But consolidation and internationalisation mean you need to address new buyers. It is the CEO and CFO of billion-dollar revenue businesses who you need to reach. It is time to break out of product/country silos and meet the new decision makers!
Healthcare Business International, now in its thirteenth year, is the only CEO-level event for the sector across Europe and Emerging Markets. In 2022 we had several hundred CEO/CXOs from major operators and over 150 investors.
3 Top reasons why leading healthcare suppliers attend:
As a supplier, no matter where you are in the world, you should join them in 2023. Here is why!
Superb networking
This is a rare opportunity to meet a wide range of operators at CEO and CXO level. And we don’t think you will find as many specialist investors in health care services at any event outside of the USA. Many of these take a hands-on approach to procurement and partnership.
Insights that let you forge partnerships
Our CEO speakers deliver real insights into everything from quality to brand and from marketing to how groups are really using ehealth. Use these insights to engage them and to forge new relationships.
The broader vision you need
A sector which was always considered national is now international. Chinese groups are buying Australians with European subsidiaries. We have seen a huge growth in Pan-European platforms. And Saudi groups are extending their rech across the Middle East. No other event offers an international view of the landscape. This event focuses on sectors such as hospitals and diagnostics AND gives you insights at regional level!
Any questions? Call us now on 00 44 207 183 3779
Here's what previous delegates have said about the conference
Perhaps it is not surprising that many health care suppliers send teams. Book your place at HBI 2023 now and join us.
What struck me was the availability of some of the brightest minds in health care. I get to meet a lot of people in a very fluid way which I could not do anywhere else.
Ronnie Van der Merwe, CEO, Mediclinic
Very beneficial for our organisation for three reasons: tremendous networking with executives; huge amount of knowledge sharing, and, thirdly, it helps with transformation with the ever changing business environment.
Janti Masani - Director for Strategic Global Accounts - Abbott
It's a great platform to discuss, deliberate and come up with solid conclusions, which could be the problem in solving for the healthcare needs. When you want to be in business in healthcare, this is a very important conference.
Shamsheer Vayalil, Chairman and Managing Director, VPS Healthcare, UAE, Middle East
I get a better view of what is going on with digital health, artificial intelligence and how the providers and payors manage within the global trends. And also their cost-cutting initiatives. I’ve never had the chance to meet other CFOs and CEOs from other private hospitals. I am meeting many of them here. I'll be catching up with them, touching base with them afterwards. It's a great experience and a great networking opportunity.
Burcu Öztürk, CFO, MLP Care
Final discount saving ends in...
See who is attending
Featured Speakers
Sessions include:
Tuesday June 20, 2023
Investing in Europe
How do major investors in the sector view the challenges it faces? How do they view environmental, societal and governance issues? In which sectors and countries do they see opportunities?
Martin Henrichs, Head of Healthcare EMEA, UBS
Nikolaus Woloszczuk, Senior Managing Partner, Stonepeak
Inaki Cobo, Partner, Private Equity, KKR
Viviana Kane, Managing Director, EQT Partners
Moderated by Max Hotopf, Founder and Chairman, HBI
Fleming - 3rd Floor
Tuesday June 20, 2023
Investing in Emerging Markets
Bearing the brunt of inadequate health systems, low and middle-income countries are ripe for investment opportunities from the private sector. This session with leading emerging market investors outlines the challenges and the opportunities for investment, growth and innovation.
Amaury Guerrero, CEO, Opty / Patria Group
Zeynep Kantur, Global Manager & Global Head of Health, IFC
Dr Stephen Sammut, Chair, Industry Advisory Board, Alta Semper Capital
Jide Olanrewaju, Managing Director, TPG Rise
Moderated by Max Ateba, Associate Partner, Dalberg Advisors
Fleming - 3rd Floor
Tuesday June 20, 2023
Investing in UK and Ireland
The UK remains by far the largest market for private equity investment in Europe. But what are the dynamics post-Covid and post-Brexit? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Katie Beckingham, Director, August Equity LLP
Alan Hughes, Founder, LIT Healthcare
James Tugendhat, CEO, HC-One
Dr Charles Niehaus, Executive Director, Affidea Group
Moderated by Sharon Lamb, Partner, McDermott, Will & Emery
Whittle - 3rd Floor
Tuesday June 20, 2023
Investing in Health Care Property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in place and what is lacking? What impact is the lack of available debt having on transactions?
Speakers include:
Stephane Pichon, Founder and Managing Partner, Your Care Consult
Steven Hamner, CFO & Co-Founder, MPT
Xavier Cheval, CEO, Icade
Moderated by Hugh Risebrow, Managing Director, Latchmore Associates
St James - 4th Floor
Tuesday June 20, 2023
Investing in DACH
The 100m population of wealthy German-speaking countries is by far the largest market for healthcare services in Europe. What will be the trajectory for future consolidation, who are the players and what is the opportunity? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Andreas Ludowig, CEO, Kinios
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Julius Hugelshofer, Senior Principal, Verlinvest
Philipp von Hammerstein, Partner, Health& Care, Gimv
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery
Backed by Triton Partners, Kinios is consolidating the German outpatient orthopaedic space. Leveraging the scale of Kielstein group, Germany’s largest primary care network, Primarmedizin is looking to build an outpatient network specialising in internal medicine.
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Nursing Homes
Growth projections have always been difficult in the elderly care sector – and now even challenged as a result of Covid- 19 and scandals which rocked the sector in 2022. Our panel of experts share their views on the opportunities and challenges as we look ahead to the next 3 years.
Speakers include:
Buyanzaya Batbileg, Head of Investment, Threestones Capital Investment
Threestones has three funds totalling more than a billion Euros investing in nursing homes in Germany, Italy and Spain
Nate McLemore, Managing Director, Columbia Pacific Management
Dr Sanjeev Kanoria, Founder and Chairman, Advinia Health Care
Moderated by Michaila Byrne, Senior Analyst, HBI
Westminster - 4th Floor
Wednesday June 21, 2023
The Outpatient Differential
Traditional hospitals face massive change. The drive towards outpatient and the creation of virtual wards promises to reduce costs and grow supply. This session looks at how and why outpatient models will shape the future of healthcare delivery globally with real data and examples of cost savings, efficiency increase and patient satisfaction.
Speakers include:
Chris Robson, Managing Director, Akeso&Co
Chris is working with NHS England to implement 40-50 virtual beds per 100,000 people. He shares the lessons learned implementing such wards, the technology required and the early outcomes from projects.
Zisis Sotiriou, Senior Vice President, Regional COO, Affidea
Vivek Shukla, Managing Partner, Surge Management Consulting
Dr Arun Thiyagarajan, Global Healthcare Transformation Director, Bupa
Moderated by Joe Quiruga, Analyst, HBI
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Mental Health
The world faces a mental health pandemic. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far are more acute psychiatric needs being addressed in the for-profit sector? Participants include Andre Schmidt, Group CEO Median, the biggest German rehabilitation group which acquired the Priory, the UK’s largest mental health provider in late 2020 and Petri Bono, CMO at Terveystalo, which has reduced mental health absences at client companies by 40%.
Speakers include:
Petri Bono, Chief Medical Officer, Terveystalo
Petri shares how Finlands largest private health and occupational health group developed new, cost efficient patient pathways that lead to a 40% decrease in mental health absences.
Dr Andre Schmidt, Group CEO, MEDIAN
Alexandra Prieux, CEO, ALCEDIAG
Simon Miller, International Partnerships Lead, Headspace Health
Moderated by Dr Stefan Schrettle, Partner, L.E.K. Consulting
St James - 4th Floor
Wednesday June 21, 2023
The evolution in Primary Care
The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging, and at how they are reimagining its delivery and business models.
Speakers include:
Dr Murray Ellender, CEO and Co-Founder, eConsult Health
Lyndsey Reeves, Director of Operations UK, Kry/Livi
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Martin Lindman, CEO, Doktor.Se
Moderated by Martin Debenito-Gellner, Senior Analyst, HBI
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.
Speakers include:
Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Nikos Paragios, CEO, TheraPanacea
Moderated by Joe Quiruga, Analyst, HBI
Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model
Fleming - 3rd Floor
Wednesday June 21, 2023
Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.
Speakers include:
Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Nikos Paragios, CEO, TheraPanacea
Moderated by Joe Quiruga, Analyst, HBI
Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model
Fleming - 3rd Floor
